Literature DB >> 17686622

Impact of the new ATS/ERS pulmonary function test interpretation guidelines.

Mary Elizabeth Kreider1, Michael A Grippi.   

Abstract

RATIONALE: In November 2005, the American Thoracic and European Respiratory Societies jointly published a statement proposing a new interpretation scheme for pulmonary function tests. The practical effect of adoption of these new guidelines has not yet been studied. The purpose of the current study was to address the effects of the new interpretation strategy on the relative distribution of obstructive and restrictive diagnoses in patients evaluated at a single academic medical center laboratory. PATIENTS/
METHODS: Pulmonary functions tests from 319 patients were analyzed according to four different interpretation schemes. The number of patients classified according to each as obstructed, restricted, neither, or both were compared, and factors associated with a change in classification using the different approaches were examined.
RESULTS: Although similar proportions of patients were identified as restricted using either the "GOLD" scheme (23%) or new approaches (22%), significantly more (P<0.005) were defined as obstructed using the newly proposed scheme (44% versus 33%). Additionally, 36% of subjects defined as obstructed using either the traditional or new schemes were classified differently (i.e., either "gained" or "lost" the diagnosis of obstruction) using the new approach. Women were significantly more likely than men to have a change in classification.
CONCLUSIONS: The new interpretation scheme leads to a diagnosis of obstruction in a greater proportion of patients undergoing pulmonary function testing. The clinical significance of this finding has not yet been validated, and its economic impact remains to be assessed.

Entities:  

Mesh:

Year:  2007        PMID: 17686622     DOI: 10.1016/j.rmed.2007.06.019

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  8 in total

1.  The lung cancer exercise training study: a randomized trial of aerobic training, resistance training, or both in postsurgical lung cancer patients: rationale and design.

Authors:  Lee W Jones; Neil D Eves; William E Kraus; Anil Potti; Jeffrey Crawford; James A Blumenthal; Bercedis L Peterson; Pamela S Douglas
Journal:  BMC Cancer       Date:  2010-04-21       Impact factor: 4.430

2.  Rationale and design of the Exercise Intensity Trial (EXCITE): A randomized trial comparing the effects of moderate versus moderate to high-intensity aerobic training in women with operable breast cancer.

Authors:  Lee W Jones; Pamela S Douglas; Neil D Eves; P Kelly Marcom; William E Kraus; James E Herndon; Brant A Inman; Jason D Allen; Jeffrey Peppercorn
Journal:  BMC Cancer       Date:  2010-10-06       Impact factor: 4.430

Review 3.  Inhaled chemotherapy in lung cancer: future concept of nanomedicine.

Authors:  Paul Zarogoulidis; Ekaterini Chatzaki; Konstantinos Porpodis; Kalliopi Domvri; Wolfgang Hohenforst-Schmidt; Eugene P Goldberg; Nikos Karamanos; Konstantinos Zarogoulidis
Journal:  Int J Nanomedicine       Date:  2012-03-22

4.  Perioperative Rehabilitation in Operable Lung Cancer Patients (PROLUCA): A Feasibility Study.

Authors:  Maja S Sommer; Karen Trier; Jette Vibe-Petersen; Malene Missel; Merete Christensen; Klaus R Larsen; Seppo W Langer; Carsten Hendriksen; Paul Frost Clementsen; Jesper H Pedersen; Henning Langberg
Journal:  Integr Cancer Ther       Date:  2016-05-04       Impact factor: 3.279

5.  Risk Evaluation of Construction Workers' Exposure to Silica Dust and the Possible Lung Function Impairments.

Authors:  Elahe Tavakol; Mansour Azari; Rezvan Zendehdel; Sousan Salehpour; Soheila Khodakrim; Saeed Nikoo; Behzad Saranjam
Journal:  Tanaffos       Date:  2017-06

6.  Non-invasive techniques to assess restrictive lung disease in workers exposed to free crystalline silica.

Authors:  Massimo Corradi; Giuseppina Folesani; Benedetta Robuschi; Luisella Selis; Maria Grazia Riccelli; Maria Grazia Riccelli; Roberta Andreoli; Roberta Pisi; Alfredo Chetta; Antonio Mutti
Journal:  Med Lav       Date:  2019-04-19       Impact factor: 1.275

7.  Perioperative rehabilitation in operation for lung cancer (PROLUCA) - rationale and design.

Authors:  Maja S Sommer; Karen Trier; Jette Vibe-Petersen; Malene Missel; Merete Christensen; Klaus R Larsen; Seppo W Langer; Carsten Hendriksen; Paul Clementsen; Jesper H Pedersen; Henning Langberg
Journal:  BMC Cancer       Date:  2014-06-04       Impact factor: 4.430

8.  Changes in Health-Related Quality of Life During Rehabilitation in Patients With Operable Lung Cancer: A Feasibility Study (PROLUCA).

Authors:  Maja S Sommer; Karen Trier; Jette Vibe-Petersen; Karl B Christensen; Malene Missel; Merete Christensen; Klaus R Larsen; Seppo W Langer; Carsten Hendriksen; Paul F Clementsen; Jesper H Pedersen; Henning Langberg
Journal:  Integr Cancer Ther       Date:  2016-10-03       Impact factor: 3.279

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.